S

Sosei Group Corp
TSE:4565

Watchlist Manager
Sosei Group Corp
TSE:4565
Watchlist
Price: 869 JPY 2.96%
Market Cap: 78.6B JPY

Sosei Group Corp
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sosei Group Corp
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Sosei Group Corp
TSE:4565
Operating Income
-ÂĄ8.5B
CAGR 3-Years
N/A
CAGR 5-Years
-35%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Operating Income
ÂĄ373.6B
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Operating Income
ÂĄ289.3B
CAGR 3-Years
51%
CAGR 5-Years
21%
CAGR 10-Years
11%
Otsuka Holdings Co Ltd
TSE:4578
Operating Income
ÂĄ457.6B
CAGR 3-Years
48%
CAGR 5-Years
16%
CAGR 10-Years
8%
Chugai Pharmaceutical Co Ltd
TSE:4519
Operating Income
ÂĄ553.2B
CAGR 3-Years
-12%
CAGR 5-Years
15%
CAGR 10-Years
21%
Astellas Pharma Inc
TSE:4503
Operating Income
ÂĄ145.8B
CAGR 3-Years
-14%
CAGR 5-Years
-3%
CAGR 10-Years
-4%
No Stocks Found

Sosei Group Corp
Glance View

Market Cap
78.6B JPY
Industry
Pharmaceuticals

Sosei Group Corp. engages in the discovery, design, and development of medicines targeting G protein-coupled receptors (GPCRs). The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 198 full-time employees. The company went IPO on 2004-07-29. The pharmaceutical business is engaged in the research, development and sales of medicines, the management of regenerative medical funds, the investment in bio venture companies related to regenerative medicine, the overseas development by licensing, the promotion of commercialization, the structural analysis of GPCR, the initial lead compound creation, the candidate search by proprietary StaR technology, as well as structural base of new drugs using GPCR related basic technology drug discovery, screening, promotion of antibody drug research and development.

Intrinsic Value
1 189.81 JPY
Undervaluation 27%
Intrinsic Value
Price
S

See Also

What is Sosei Group Corp's Operating Income?
Operating Income
-8.5B JPY

Based on the financial report for Sep 30, 2025, Sosei Group Corp's Operating Income amounts to -8.5B JPY.

What is Sosei Group Corp's Operating Income growth rate?
Operating Income CAGR 5Y
-35%

Over the last year, the Operating Income growth was -94%.

Back to Top